Zynex introduces NeuroMove stroke aid device into U.S. market

Monday February 5, 2018 0 comments Tags: Lone Tree, Zynex, NeuroMove, Thomas Sandgaard

LONE TREE -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced the introduction of the NeuroMove device into its expanding direct sales force in the U.S. market.Zynex_logoUSE

The NeuroMove™ is a device designed to aid stroke survivors regain movement using the brain's ability to rewire itself, also known as "neuro-plasticity," the company said.

"I am excited to announce that we are re-launching the NeuroMove 900 stroke and traumatic brain injury rehabilitation product to our sales force over the next couple of months,” said Thomas Sandgaard, Zynex founder and CEO.

“We have for many years sold the NeuroMove device primarily to rehabilitation clinics in the US as well as internationally and while the device is designed with home use in mind we have not previously promoted it through our direct sales force.

“The NeuroMove 900 is a complimentary product for a large portion of our direct sales force aimed at the rehabilitation market.  Stroke is the leading cause of serious, long-term disability in the United States and the NeuroMove 900 is uniquely positioned to enhance the patient's recovery. 

“Under a newly designed marketing strategy, healthcare practitioners will be able to use the NeuroMove 900 on patients clinically and then easily transition the patient's rehabilitation to the patient's home once discharged from the clinic. 

“Over the years, the number of rehabilitation visits allowed by insurance companies for stroke victims has decreased and the importance of products like the NeuroMove which allows patients to continue their recovery at home has increased.

"We continue to grow our direct sales force which expands our geographic footprint across the US.  This will complement our existing distribution of our flagship product, the NexWave, primarily focused on prescription strength pain relief."

For more information about the NeuroMove device, visit www.zynexneuro.com/neuromove